Cannabis Oils Generates Substantial Revenue

0

A company that has over 40 years experience in the medical cannabis industry on the next BTV. CannTrust is the leader in the league so to speak in terms of revenue from value-added products. Almost two thirds of its revenue last quarter came from the sale of cannabis oils and these products generate higher prices and higher margins than traditional dried cannabis does.

Our number one priority at CannTrust™ is to ensure that our customers have the knowledge and support they need when purchasing medical cannabis. Our team of nurses, MD’s, and pharmacists are ready to answer your questions and recommend strains to meet your condition.

As a federally regulated licensed producer, we bring more than 40 years of pharmacy and healthcare experience to the Medical Cannabis industry and apply this expertise to produce standardized Medical Cannabis for patients in need as we sell 100% pesticide free product.

At CannTrust™ we are committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive Pharma partner Apotex are diligently innovating and developing products that will make it easier for patients to use Medical Cannabis today and in the future. We support ongoing patient education about Medical Cannabis, and have launched a compassionate use program to support patients with financial needs.

For more information on CannTrust (TRST:CSE) please fill out the form below.

 

Request Investor Kit

Name*

Email*

*Required.